Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Tamoxifen × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 22 Carcinoma, Intraductal, Noninfiltrating 6 Breast Carcinoma In Situ 3 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pinealoma 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Medulloblastoma 1 Infertility 1 HR Positive HER2 Negative Advanced Breast Cancer 1 Glioblastoma 1 Endometrial Neoplasms 1 ERα+ Breast Cancer 1 ER+ Breast Cancer 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 21 venetoclax 19 Dexamethasone 17 pembrolizumab 16 fludarabine 14 Cytarabine 13 Gemcitabine 10 Azacitidine 9 pomalidomide 8 Rituximab 8 Lenalidomide 8 Carboplatin 8 selinexor 7 glofitamab 7 fludarabine phosphate 7 Cisplatin 7 daratumumab 6 Temozolomide 6 Paclitaxel 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Oxaliplatin 5 Immunotherapy, Adoptive 5 Decitabine 5 ruxolitinib 4 Surgical Procedures, Operative 4 Nivolumab 4 Drug Therapy 4 Cladribine 4 Calcium Dobesilate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06914674 2025-04-06

SPTP

Fudan University

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡